Covered recipient · General Payments record
LESLIE L POPPLEWELL
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2019–2024
$57,073.03
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,137.50 | 2 |
| Food and Beverage | $349.90 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kite Pharma, Inc. | $4,491.70 | 3 |
| Novartis Pharma AG | $1,687.50 | 1 |
| PFIZER INC. | $82.74 | 1 |
| ABBVIE INC. | $80.68 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.16 | 2 |
| BeiGene USA, Inc. | $27.62 | 1 |
| Celgene Corporation | $25.50 | 1 |
| PharmaEssentia USA Corporation | $24.83 | 1 |
| Janssen Biotech, Inc. | $21.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.28 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105294439 | CMS |
| ABBVIE INC. | $26.34 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105294443 | CMS |
| ABBVIE INC. | $23.06 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105294446 | CMS |
| BeiGene USA, Inc. | $27.62 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120852809 | CMS |
| Celgene Corporation | $25.50 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101184747 | CMS |
| Janssen Biotech, Inc. | $21.67 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078293727 | CMS |
| Kite Pharma, Inc. | $4,450.00 | 01/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1128610731 | CMS |
| Kite Pharma, Inc. | $12.15 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128610733 | CMS |
| Kite Pharma, Inc. | $29.55 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128610735 | CMS |
| Novartis Pharma AG | $1,687.50 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152815213 | CMS |
| Novartis Pharmaceuticals Corporation | $27.32 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087156357 | CMS |
| Novartis Pharmaceuticals Corporation | $17.84 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087156361 | CMS |
| PFIZER INC. | $82.74 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131229029 | CMS |
| PharmaEssentia USA Corporation | $24.83 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137308640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.